Ocular pharmacokinetic modeling using corneal absorption and desorption rates from in vitro permeation experiments with cultured corneal epithelial cells

被引:32
作者
Ranta, VP [1 ]
Laavola, M [1 ]
Toropainen, E [1 ]
Vellonen, KS [1 ]
Talvitie, A [1 ]
Urtti, A [1 ]
机构
[1] Univ Kuopio, Dept Pharmaceut, FIN-70211 Kuopio, Finland
关键词
ocular absorption; pharmacokinetic modeling; corneal epithelium; cell culture; cassette dosing; timolol;
D O I
10.1023/A:1025754026449
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To determine corneal absorption and desorption rate constants in a corneal epithelial cell culture model and to apply them to predict ocular pharmacokinetics after topical ocular drug application. Method. In vitro permeation experiments were performed with a mixture of six beta-blockers using an immortalized human corneal epithelial cell culture model. Disappearance of the compounds from the apical donor solution and their appearance in the basolateral receiver solution were determined and used to calculate the corneal absorption and desorption rate constants. An ocular pharmacokinetic simulation model was constructed for timolol with the Stella(R) program using the absorption and desorption rate constants and previously published in vivo pharmacokinetic parameters. Results. The corneal absorption rates of beta-blockers increased significantly with the lipophilicity of the compounds. The pharmacokinetic simulation model gave a realistic mean residence time for timolol in the cornea (57 min) and the aqueous humor (90 min). The simulated timolol concentration in the aqueous humor was about 1.8 times higher than the previously published experimental values. Conclusions. The simulation model gave a reasonable estimate of the aqueous humor concentration profile of timolol. This was the first attempt to combine cell culture methods and pharmacokinetic modeling for prediction of ocular pharmacokinetics. The wider applicability of this approach remains to be seen.
引用
收藏
页码:1409 / 1416
页数:8
相关论文
共 32 条
[1]   PHYSICOCHEMICAL DETERMINANTS OF DRUG DIFFUSION ACROSS THE CONJUNCTIVA, SCLERA, AND CORNEA [J].
AHMED, I ;
GOKHALE, RD ;
SHAH, MV ;
PATTON, TF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (08) :583-586
[2]   DISPOSITION OF TIMOLOL AND INULIN IN THE RABBIT EYE FOLLOWING CORNEAL VERSUS NON-CORNEAL ABSORPTION [J].
AHMED, I ;
PATTON, TF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1987, 38 (1-3) :9-21
[3]  
ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
[4]   THE USE OF CULTURED EPITHELIAL AND ENDOTHELIAL-CELLS FOR DRUG TRANSPORT AND METABOLISM STUDIES [J].
AUDUS, KL ;
BARTEL, RL ;
HIDALGO, IJ ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1990, 7 (05) :435-451
[5]   Xyloglucan as a novel vehicle for timolol: Pharmacokinetics and pressure lowering activity in rabbits [J].
Burgalassi, S ;
Chetoni, P ;
Panichi, L ;
Boldrini, E ;
Saettone, MF .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (06) :497-509
[6]   Air-interface condition promotes the formation of tight corneal epithelial cell layers for drug transport studies [J].
Chang, JE ;
Basu, SK ;
Lee, VHL .
PHARMACEUTICAL RESEARCH, 2000, 17 (06) :670-676
[7]   RELATIVE EFFECTIVENESS OF PRODRUG AND VISCOUS SOLUTION APPROACHES IN MAXIMIZING THE RATIO OF OCULAR TO SYSTEMIC ABSORPTION OF TOPICALLY APPLIED TIMOLOL [J].
CHANG, SC ;
CHIEN, DS ;
BUNDGAARD, H ;
LEE, VHL .
EXPERIMENTAL EYE RESEARCH, 1988, 46 (01) :59-69
[8]   NASAL AND CONJUNCTIVAL CONTRIBUTIONS TO THE SYSTEMIC ABSORPTION OF TOPICAL TIMOLOL IN THE PIGMENTED RABBIT - IMPLICATIONS IN THE DESIGN OF STRATEGIES TO MAXIMIZE THE RATIO OF OCULAR TO SYSTEMIC ABSORPTION [J].
CHANG, SC ;
LEE, VHL .
JOURNAL OF OCULAR PHARMACOLOGY, 1987, 3 (02) :159-169
[9]   CORNEAL AND CONJUNCTIVAL SCLERAL PENETRATION OF PARA-AMINOCLONIDINE, AGN-190342, AND CLONIDINE IN RABBIT EYES [J].
CHIEN, DS ;
HOMSY, JJ ;
GLUCHOWSKI, C ;
TANGLIU, DDS .
CURRENT EYE RESEARCH, 1990, 9 (11) :1051-1059
[10]   ROLE OF ENZYMATIC LABILITY IN THE CORNEAL AND CONJUNCTIVAL PENETRATION OF TIMOLOL ESTER PRODRUGS IN THE PIGMENTED RABBIT [J].
CHIEN, DS ;
SASAKI, H ;
BUNDGAARD, H ;
BUUR, A ;
LEE, VHL .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :728-733